Cargando…
The impact of hospital-acquired bloodstream infections.
Nosocomial bloodstream infections are a leading cause of death in the United States. If we assume a nosocomial infection rate of 5%, of which 10% are bloodstream infections, and an attributable mortality rate of 15%, bloodstream infections would represent the eighth leading cause of death in the Uni...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631709/ https://www.ncbi.nlm.nih.gov/pubmed/11294700 |
_version_ | 1782163966914461696 |
---|---|
author | Wenzel, R P Edmond, M B |
author_facet | Wenzel, R P Edmond, M B |
author_sort | Wenzel, R P |
collection | PubMed |
description | Nosocomial bloodstream infections are a leading cause of death in the United States. If we assume a nosocomial infection rate of 5%, of which 10% are bloodstream infections, and an attributable mortality rate of 15%, bloodstream infections would represent the eighth leading cause of death in the United States. Because most risk factors for dying after bacteremia or fungemia may not be changeable, prevention efforts must focus on new infection-control technology and techniques. |
format | Text |
id | pubmed-2631709 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-26317092009-05-20 The impact of hospital-acquired bloodstream infections. Wenzel, R P Edmond, M B Emerg Infect Dis Research Article Nosocomial bloodstream infections are a leading cause of death in the United States. If we assume a nosocomial infection rate of 5%, of which 10% are bloodstream infections, and an attributable mortality rate of 15%, bloodstream infections would represent the eighth leading cause of death in the United States. Because most risk factors for dying after bacteremia or fungemia may not be changeable, prevention efforts must focus on new infection-control technology and techniques. Centers for Disease Control and Prevention 2001 /pmc/articles/PMC2631709/ /pubmed/11294700 Text en |
spellingShingle | Research Article Wenzel, R P Edmond, M B The impact of hospital-acquired bloodstream infections. |
title | The impact of hospital-acquired bloodstream infections. |
title_full | The impact of hospital-acquired bloodstream infections. |
title_fullStr | The impact of hospital-acquired bloodstream infections. |
title_full_unstemmed | The impact of hospital-acquired bloodstream infections. |
title_short | The impact of hospital-acquired bloodstream infections. |
title_sort | impact of hospital-acquired bloodstream infections. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631709/ https://www.ncbi.nlm.nih.gov/pubmed/11294700 |
work_keys_str_mv | AT wenzelrp theimpactofhospitalacquiredbloodstreaminfections AT edmondmb theimpactofhospitalacquiredbloodstreaminfections AT wenzelrp impactofhospitalacquiredbloodstreaminfections AT edmondmb impactofhospitalacquiredbloodstreaminfections |